US Patent Issued to The University of North Carolina at Chapel Hill, The General Hospital on Sept. 30 for "Methods and compositions for chimeric antigen receptor targeting cancer cells" (North Carolina, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,490, issued on Sept. 30, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.) and The General Hospital Corp. (Boston).

"Methods and compositions for chimeric antigen receptor targeting cancer cells" was invented by Gianpietro Dotti (Chapel Hill, N.C.), Soldano Ferrone (Boston), Hannah Reid Hudson (Durham, N.C.), Elena Dukhovlinova (Chapel Hill, N.C.), Cristina Ferrone (Boston) and Xinhui Wang (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a chimeric antigen receptor (CAR) that recognizes CSPG4 as well as methods of use in the treatment of diseases and disorders."

The patent was ...